Literature DB >> 15654786

Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.

Vito Annese1, Giovanni Lombardi, Francesco Perri, Renata D'Incà, Sandro Ardizzone, Gabriele Riegler, Stelio Giaccari, Maurizio Vecchi, Fabiana Castiglione, Paolo Gionchetti, Elena Cocchiara, Sergio Vigneri, Anna Latiano, Orazio Palmieri, Angelo Andriulli.   

Abstract

BACKGROUND: Three major variants of the CARD15 gene confer susceptibility to Crohn's disease (CD). Whether or not these variants correlate with specific clinical features of the disease is under evaluation. AIM: We investigated the possible association of CARD15 variants with specific clinical characteristics, including the occurrence of anti-Saccharomyces cerevisiae antibodies (ASCA) and antineutrophil cytoplasmic antibodies (ANCA), in a large cohort of inflammatory bowel disease (IBD) patients and their unaffected relatives.
METHODS: Three hundred and sixteen CD patients (156 with positive family history), 408 ulcerative colitis (UC) patients (206 with positive family history), 588 unaffected relatives, and 205 unrelated healthy controls (HC) were studied. Single nucleotide polymorphisms (SNPs) R702W, G908R, and L1007finsC of the CARD15 gene were investigated and correlated to age at diagnosis, gender, family history, localization, extraintestinal manifestations, previous resective surgery, stenosing/fistulizing pattern, ANCA, and ASCA.
RESULTS: Compared to HC, the frequencies of all three variants in CD were significantly increased: 8.7% versus 4.1% for R702W (p < 0.006), 7.3% versus 2.7% for G908R (p < 0.002), 9.3% versus 0.7% for L1007finsC (p < 0.00001). At least one risk allele was found in 38.2% (p < 0.0001, compared to HC), 13.7% (NS), and 15.1% of CD, UC, and HC, respectively. The L1007finsC risk allele was also significantly increased in unaffected relatives of familial (9.5%; p < 0.00001), and sporadic CD (9%; p < 0.00001), compared to HC (0.7%). Sixteen healthy relatives, carriers of two risk alleles, were asymptomatic after 5-8 yr of follow-up. CD carriers of at least one variant were younger (p= 0.03), more likely to have ileal localization (p= 0.0001), stenosing pattern (p= 0.01), previous resective surgery (p= 0.0001), and presence of ASCA (p= 0.0001). No difference in SNPs frequency between familial and sporadic cases of CD was found.
CONCLUSION: In our population, both familial and sporadic CD patients carrying at least one major variant of CARD15 had an aggressive clinical course.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654786     DOI: 10.1111/j.1572-0241.2005.40705.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  30 in total

Review 1.  Host-microbiome interaction in Crohn's disease: A familiar or familial issue?

Authors:  Andrea Michielan; Renata D'Incà
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

2.  Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease.

Authors:  Travis B Murdoch; Wei Xu; Joanne M Stempak; Carol Landers; Stephan R Targan; Jerome I Rotter; Mark S Silverberg
Journal:  Inflamm Bowel Dis       Date:  2012-01-24       Impact factor: 5.325

3.  CARD15 mutations and colorectal cancer in a South European country.

Authors:  Paulo Freire; Francisco Portela; Maria M Donato; Pedro Figueiredo; Manuela Ferreira; Pedro Amaro; Anabela Sá; Paulo Andrade; Hermano Gouveia; Carlos Sofia
Journal:  Int J Colorectal Dis       Date:  2010-07-30       Impact factor: 2.571

Review 4.  Familial aggregation in inflammatory bowel disease: is it genes or environment?

Authors:  Tiago Nunes; Gionata Fiorino; Silvio Danese; Miquel Sans
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

5.  Prediction of Crohn's disease aggression through NOD2/CARD15 gene sequencing in an Australian cohort.

Authors:  Maneesha Bhullar; Finlay Macrae; Gregor Brown; Margie Smith; Ken Sharpe
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

6.  Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository.

Authors:  Mamatha Bhat; Geoffrey C Nguyen; Pierre Pare; Raymond Lahaie; Colette Deslandres; Edmond-Jean Bernard; Guy Aumais; Gilles Jobin; Gary Wild; Albert Cohen; Diane Langelier; Steven Brant; Themistocles Dassopoulos; Dermot McGovern; Esther Torres; Richard Duerr; Miguel Regueiro; Mark S Silverberg; Hillary Steinhart; Anne M Griffiths; Abdul Elkadri; Judy Cho; Deborah Proctor; Philippe Goyette; John Rioux; Alain Bitton
Journal:  Am J Gastroenterol       Date:  2009-06-09       Impact factor: 10.864

Review 7.  Current understanding of fungal microflora in inflammatory bowel disease pathogenesis.

Authors:  David Underhill; Jonathan Braun
Journal:  Inflamm Bowel Dis       Date:  2008-08       Impact factor: 5.325

8.  Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease.

Authors:  Mirjam Bueno de Mesquita; Marc Ferrante; Liesbet Henckaerts; Marie Joossens; Virginie Janssens; Tibor Hlavaty; Marie Pierik; Sofie Joossens; Nele Van Schuerbeek; Gert Van Assche; Paul Rutgeerts; Severine Vermeire; Ilse Hoffman
Journal:  Eur J Pediatr       Date:  2008-08-01       Impact factor: 3.183

9.  Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases.

Authors:  S Cucchiara; A Latiano; O Palmieri; A M Staiano; R D'Incà; G Guariso; G Vieni; V Rutigliano; O Borrelli; M R Valvano; V Annese
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

10.  Serologic investigations in children with inflammatory bowel disease and food allergy.

Authors:  Urszula Grzybowska-Chlebowczyk; Halina Woś; Aleksander L Sieroń; Sabina Wiecek; Aleksandra Auguściak-Duma; Halina Koryciak-Komarska; Joanna Kasznia-Kocot
Journal:  Mediators Inflamm       Date:  2009-12-06       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.